Scott E. Royer - Mar 31, 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Chief Financial Officer
Signature
/s/ Scott E. Royer
Stock symbol
VCNX
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/3/2023, 04:32 PM
Previous filing
Apr 4, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 4.5K Mar 31, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +32K $0.00 32K Mar 31, 2023 Common Stock 32K $0.40 Direct F5
holding VCNX Stock Option (Right to Buy) 25K Mar 31, 2023 Common Stock 25K $13.60 Direct F1
holding VCNX Stock Option (Right to Buy) 1.5K Mar 31, 2023 Common Stock 1.5K $3.90 Direct F1
holding VCNX Stock Option (Right to Buy) 2K Mar 31, 2023 Common Stock 2K $6.07 Direct F2
holding VCNX Stock Option (Right to Buy) 6K Mar 31, 2023 Common Stock 6K $2.93 Direct F3
holding VCNX Stock Option (Right to Buy) 16K Mar 31, 2023 Common Stock 16K $1.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully exercisable as of the date of this report.
F2 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
F3 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
F4 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
F5 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date.